312-422-1111 [email protected]
  • Stay Updated
  • Become a Member
  • Business Solutions
  • Contact Us
iBIO
  • About
    • Who We Are
    • Leadership
    • Contact
  • PROGRAMS
    • Events Calendar
    • Annual iCON Awards
    • Policy & Advocacy
      • Advocacy Center
      • Advocacy Toolkit
      • Rare Disease
    • Business Solutions
    • STEMgirls Camp – Chicago
    • LabShare
    • STEMKits
    • StellarGirls
    • BioGENEius Illinois
  • Membership
    • Member Benefits
    • Join iBIO
  • Resources
    • News
    • Member Committees
    • Daily Newsletter
    • IBIO Reports
      • About Illinois
      • Investment Report
      • State Incentives
Select Page
iBIO Releases Inaugural Member Investor Portfolio Report Showcasing $1.24 Billion in Illinois Life Sciences Investment

iBIO Releases Inaugural Member Investor Portfolio Report Showcasing $1.24 Billion in Illinois Life Sciences Investment

by John Conrad | Aug 5, 2025 | iBIO News

Report highlights nearly 100 life science companies and investment trends as Chicago prepares to welcome BIO International Convention 2030 CHICAGO, IL – August 5, 2025 – The Illinois Biotechnology Innovation Organization (iBIO) today released its inaugural Member...
Capital Pulse: Flow Medical Secures $5M Seed Round, Including First-Ever UCM Ventures Investment

Capital Pulse: Flow Medical Secures $5M Seed Round, Including First-Ever UCM Ventures Investment

by John Conrad | Dec 18, 2024 | Capital Pulse

Flow Medical, a startup spun out of UChicago Medicine, has secured $5 million in seed funding, with UCM Ventures making its inaugural investment in the company. The startup, founded by three University of Chicago faculty members, is developing a specialized catheter...
New Report Highlights Illinois Life Sciences Industry’s Remarkable Growth and Economic Impact

New Report Highlights Illinois Life Sciences Industry’s Remarkable Growth and Economic Impact

by John Conrad | Dec 2, 2024 | iBIO News

The newly released TECONOMY/BIO report, “The U.S. Bioscience Economy: Driving Economic Growth and Opportunity in States and Regions,” paints an impressive picture of Illinois’ life sciences industry. The data reveals an industry that’s not just...
Chicago’s Pathos AI Raises $62M to Advance AI-Driven Drug Development

Chicago’s Pathos AI Raises $62M to Advance AI-Driven Drug Development

by John Conrad | Oct 30, 2024 | Member News, NewsBrief

Pathos AI, a Chicago-based biotech startup, has secured $62 million in Series C funding to advance its AI-driven approach to drug development, according to a Tuesday press release. The funding news, also covered by Katherine Davis of Crain’s Chicago Business and...
Biopharma Sector Experiences Shift in Venture Funding and Investment Trends in Q1 2024

Biopharma Sector Experiences Shift in Venture Funding and Investment Trends in Q1 2024

by John Conrad | Jun 6, 2024 | NewsBrief

The biopharma sector has undergone significant changes in venture funding and investment trends during the first quarter of 2024, according to a recent PitchBook report. Despite a decrease in deal count, the sector saw an increase in venture funding, with $7.4 billion...
« Older Entries
  • Home
  • About Us
  • Business Solutions
  • Advocacy
  • News
  • Join iBIO
  • Contact Us
  • Facebook
  • X
  • RSS
© 2022 iBIO | All Rights Reserved | Powered by BIRKEY.COM
X